Martenyi, F.
17  Ergebnisse:
Personensuche X
?
1

mGlu2/3 Agonists – a New Approach to the Treatment of Schiz..:

Mosolov, S. N. ; Smulevich, A. B. ; Neznanov, N. G....
Neuroscience and Behavioral Physiology.  41 (2011)  6 - p. 559-566 , 2011
 
?
2

P.7.c.003 Atomoxetine in the treatment of psychostimulant-n..:

Martenyi, F. ; Zavadenko, N. ; Jarkova, N.
European Neuropsychopharmacology.  16 (2006)  - p. S527-S528 , 2006
 
?
3

P.3.027 Fluoxetine in the treatment of combat relatedPTSD: ..:

Martenyi, F. ; Basson, B.B.
European Neuropsychopharmacology.  14 (2004)  - p. S315 , 2004
 
?
4

P.1.191 No clinically significant weight changes associated..:

Grunze, H. ; Severus, E. ; Martenyi, F..
European Neuropsychopharmacology.  13 (2003)  - p. S256 , 2003
 
?
6

Fluoxetine in patients with combat-related posttraumatic st..:

Ceric, I. ; Folnegovic-Smalc, V. ; Grbesa, G....
European Neuropsychopharmacology.  11 (2001)  - p. S300-S301 , 2001
 
?
7

Fluoxetine versus placebo in posttraumatic stress disorder:

Martenyi, F. ; Brown, E. ; Zhang, H...
European Neuropsychopharmacology.  11 (2001)  - p. S193-S194 , 2001
 
?
9

Olanzapine versus chlorpromazine in Turkey:

Mraz, K. ; Gogus, A. ; Tunca, Z...
Schizophrenia Research.  41 (2000)  1 - p. 190 , 2000
 
?
 
?
 
?
13

Olanzapine versus clozapine in patients non-responsive or i..:

Bitter, I. ; Brook, S. ; Dossenbach, M....
European Neuropsychopharmacology.  9 (1999)  - p. 288 , 1999
 
?
14

On the clinical experience and pharmacology of presynaptic ..:

Martenyi, F. ; Harangozo, J.
European Neuropsychopharmacology.  2 (1992)  3 - p. 345 , 1992
 
1-15